Skip to main content
. 2022 Jun 22;29(38):57054–57066. doi: 10.1007/s11356-022-21553-8

Table 2.

Scientific production on the different COVID-19 vaccine types by institution, country, and journal (2020-2021).

Vaccine type Institutions TSP %TSP Country TSP %TSP Journals TSP %TSP
mRNA Pfizer-BioNTech Tel Aviv University 57 9.9 USA 119 20.7 Vaccines 47 8.2
Sackler Faculty of Medicine 51 8.6 Italy 96 16.7 BMJ British Medical Journal 23 4
Chaim Sheba Medical Center 25 4.3 Israel 84 14.6 New England Journal of Medicine 20 3.5
Institut National de la Santé et de la Recherche Médicale (Inserm) 21 3.6 England 50 8.7 Vaccine 14 2.4
University of London 21 3.6 Germany 48 8.3 Frontiers in Immunology 12 2.1
Moderna University of California System 18 8.6 USA 111 52.9 New England Journal of Medicine 22 10.5
Harvard University 17 8.1 Spain 14 6.7 Cureus 14 6.7
Emory University 16 7.6 Germany 13 6.2 BMJ British Medical Journal 7 3.3
National Institutes of Health (NIH USA) 16 7.6 Canada 12 5.7 Frontiers in Immunology 6 2.9
National Institute of Allergy Infectious Diseases (NIAID) 14 6.7 Italy 10 4.8 Vaccines 5 2.4
Viral vectors AstraZeneca University of Oxford 21 9.4 England 43 19.3 Vaccines 17 7.6
Imperial College London 10 4.5 USA 22 9.9 BMJ British Medical Journal 16 7.2
University of London 9 4 India 20 9 Frontiers in Immunology 5 2.2
National and Kapodistrian University of Athens 6 2.7 Italy 19 8.5 BMJ Case Reports 4 1.8
Public Health England 6 2.7 Australia 14 6.3 Cureus 4 1.8
J&J Janssen Harvard University 9 16.1 USA 34 60.7 New England Journal of Medicine 9 16.1
Janssen Vaccines 9 16.1 Netherlands 13 23.2 JAMA Journal of the American Medical Association 4 7.1
Beth Israel Deaconess Medical Center 8 14.3 Belgium 10 17.9 JAMA Network Open 3 5.4
Janssen Pharmaceuticals 8 14.3 Italy 4 7.1 American Journal of Emergency Medicine 2 3.6
Johnson &Johnson 8 14.3 England 3 5.4 Cureus 2 3.6

TSP (Total Studies Produced). %TSP (Percentage of total studies produced)